Huggett Jim F, McHugh Timothy D, Zumla Alimuddin
Centre for Infectious Diseases, Royal Free and University College Medical School, University College London, Windeyer Building, W1T 4JF London, UK.
Int J Biochem Cell Biol. 2003 Oct;35(10):1407-12. doi: 10.1016/s1357-2725(03)00102-x.
Tuberculosis (TB) is one of the major infectious causes of morbidity and mortality worldwide. TB is difficult to control due to the time taken for the microbiological diagnosis; typically culture on solid media takes 6-8 weeks. There are number of rapid molecular methods that have been developed to diagnose new cases of tuberculosis, detect drug resistance and identify the type of mycobacteria. These assays are based on recognition of mycobacterial DNA sequences and the subsequent amplification of nucleic acid sequences to facilitate detection. This review will describe some of the molecular assays that are in use for TB diagnosis and the considerations in designing and performing such assays. Early diagnosis of tuberculosis is critical for the successful management of patients allowing informed use of chemotherapy ensuring that the right patients are treated with the right antimicrobials.
结核病是全球主要的感染性发病和死亡原因之一。由于微生物诊断所需时间,结核病难以控制;通常在固体培养基上培养需要6至8周。已经开发了许多快速分子方法来诊断结核病新病例、检测耐药性并鉴定分枝杆菌类型。这些检测基于对分枝杆菌DNA序列的识别以及随后核酸序列的扩增以促进检测。本综述将描述一些用于结核病诊断的分子检测方法以及设计和进行此类检测时的注意事项。结核病的早期诊断对于患者的成功管理至关重要,可使化疗得到明智使用,确保合适的患者接受合适的抗菌药物治疗。